Obesity is associated with atypia in breast ductal lavage of women with proliferative breast disease

Cancer Epidemiology

Volumn 33, Issue 3-4, 2009, Pages 242-248

  Djuric, Zora ^a   Edwards, Ann ^b   Madan, Shashi ^b   Darga, Linda ^b   Ren, Jianwei ^a   Blake, Cassann ^b   Koletsky, Mathew ^a   Heilbrun, Lance K ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

Author keywords

Breast ductal lavage; Nuclear morphometry; Obesity; Proliferative breast disease

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ARTICLE; BODY MASS; BREAST DISEASE; BREAST DUCTAL LAVAGE; CANCER RISK; CELL STRUCTURE; CORRELATION ANALYSIS; DIETARY INTAKE; DISEASE ASSOCIATION; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; IMAGE ANALYSIS; LAVAGE; MAJOR CLINICAL STUDY; MORPHOMETRICS; NIPPLE ASPIRATION; OBESITY; PILOT STUDY; PRIORITY JOURNAL; PROLIFERATIVE BREAST DISEASE;

ADULT; BODY FLUIDS; BODY MASS INDEX; BREAST DISEASES; BREAST NEOPLASMS; C-REACTIVE PROTEIN; EPITHELIAL CELLS; FEMALE; HUMANS; INFLAMMATION; IRRIGATION; MIDDLE AGED; NIPPLES; OBESITY; PILOT PROJECTS;

EID: 70349737788     PISSN: 18777821     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canep.2009.07.003     Document Type: Article

References (52)

1. Dupont W.D., Parl F.F., Hartmann W.H., Brinton L.A., Winfield A.C., Worrell J.A., et al. Breast cancer risk associated with proliferative breast disease and atypical hyperplasia. Cancer 71 (1993) 1258-1265 [see comments]
2. Connolly J.L., and Schnitt S.J. Clinical and histologic aspects of proliferative and non-proliferative benign breast disease. J Cell Biochem-Suppl 17G (1993) 45-48
3. Bodian C.A., Perzin K.H., Lattes R., Hoffmann P., and Abernathy T.G. Prognostic significance of benign proliferative breast disease. Cancer 71 (1993) 3896-3907 [see comments]
4. Worsham M.J., Raju U., Lu M., Kapke A., Botttrell A., Cheng J., et al. Risk factors for breast cancer from benign breast disease in a diverse population. Breast Cancer Res Treat 111 (2008) 289-296
5. Haagensen Jr. D.E. Is cystic disease related to breast cancer?. Am J Surg Pathol 15 (1991) 687-694
6. Lundin C.P., Mertens F., Rizou H., Idvall I., Georgiou G., Ingvar C., et al. Cytogenetic changes in benign proliferative and nonproliferative lesions of the breast. Cancer Genet Cytogenet 107 (1998) 118-120
7. Dawson P.J., Wolman S.R., Tait L., Heppner G.H., and Miller F.R. MCF10AT: a model for the evolution of cancer from proliferative breast disease. Am J Pathol 148 (1996) 313-319
8. Gertig D.M., Stillman I.E., Byrne C., Spiegelman D., Schnitt S.J., Connolly J.L., et al. Association of age and reproductive factors with benign breast tissue composition. Cancer Epidemiol Biomarkers Prev 8 (1999) 873-879
9. Frost A.R., Tabbara S.O., Poprocky L.A., Weiss H., and Sidawy M.K. Cytologic features of proliferative breast disease: a study designed to minimize sampling error. Cancer 90 (2000) 33-40
10. King E.B., Barrett D., King M.C., and Petrakis N.L. Cellular composition of the nipple aspirate specimen of breast fluid. I. The benign cells. Am J Clin Pathol 64 (1975) 728-738
11. Skolnick M.H., Cannon-Albright L.A., Goldgar D.E., Ward J.H., Marshall C.J., Schumann G.B., et al. Inheritance of proliferative breast disease in breast cancer kindreds. Science 250 (1990) 1715-1720
12. Rohan T.E., Negassa A., Chlebowski R.T., Habel L., McTiernan A., Ginsberg M., et al. Conjugated equine estrogen and risk of benign proliferative breast disease: a randomized controlled trial. J Natl Cancer Inst 100 (2008) 563-571
13. Page D.L., Dupont W.D., Rogers L.W., and Rados M.S. Atypical hyperplastic lesions of the female breast. A long-term follow-up study. Cancer 55 (1985) 2698-2708
14. Collins L.C., Baer H.J., Tamimi R.M., Connolly J.L., Colditz G.A., and Schnitt S.J. Magnitude and laterality of breast cancer risk according to histologic type of atypical hyperplasia: results from the Nurses' Health Study. Cancer 109 (2007) 180-187
15. Galvan-Portillo M., Torres-Sanchez L., and Lopez-Carrillo L. Dietary and reproductive factors associated with benign breast disease in Mexican women. Nutr Cancer 43 (2002) 133-140
16. Byrne C., Webb P.M., Jacobs T.W., Peiro G., Schnitt S.J., Connolly J.L., et al. Alcohol consumption and incidence of benign breast disease. Cancer Epidemiol Biomarkers Prev 11 (2002) 1369-1374
17. Kaiser R., Marcus M., Blanck H.M., Naughton M., Zhang R.H., Henderson A.K., et al. Polybrominated biphenyl exposure and benign breast disease in a cohort of US women. Ann Epidemiol 13 (2003) 16-23
18. Lampe J.W., Nishino Y., Ray R.M., Wu C., Li W., Lin M.G., et al. Plasma isoflavones and fibrocystic breast conditions and breast cancer among women in Shanghai, China. Cancer Epidemiol Biomarkers Prev 16 (2007) 2579-2586
19. Li W., Ray R.M., Lampe J.W., Lin M.G., Gao D.L., Wu C., et al. Dietary and other risk factors in women having fibrocystic breast conditions with and without concurrent breast cancer: a nested case-control study in Shanghai, China. Int J Cancer 115 (2005) 981-993
20. Mommers E.C., Page D.L., Dupont W.D., Schuyler P., Leonhart A.M., Baak J.P., et al. Prognostic value of morphometry in patients with normal breast tissue or usual ductal hyperplasia of the breast. Int J Cancer 95 (2001) 282-285
21. Radakovich K., Heilbrun L.K., Venkatranamamoorthy R., Lababidi S., Klurfeld D.M., and Djuric Z. Women participating in a dietary intervention trial maintain dietary changes without much effect on household members. Nutr Cancer 55 (2006) 44-52
22. Block G., Woods M., Potosky A., and Clifford C. Validation of a self-administered diet history questionnaire using multiple diet records. J Clin Epidemiol 43 (1990) 1327-1335
23. National Cancer Institute. Breast Cancer Risk Assessment Tool; 2008.
24. Djuric Z., Ren J., Mekhovich O., Venkatranamoorthy R., and Heilbrun LK. Effects of high fruit-vegetable and/or low-fat intervention on plasma micronutrient levels. J Am Coll Nutr 25 3 (2006) 178-187
25. Ellin A., van den Berg S., and Strandvik B. A simplified analysis of fatty acids in serum phospholipids using Sep-Pak cartridges. Clin Chim Acta 200 (1991) 59-61
26. Eder K. Gas chromatographic analysis of fatty acid methyl esters. J Chromatogr B 671 (1995) 113-131
27. Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat 6 (1979) 65-70
28. Bowman S.A., Lino M., Gerrior S.A., and Basiotis P.P. The Healthy Eating Index 1994-96. Center for Nutrition Policy and Promotion (1998), U.S. Department of Agriculture, Washington, DC
29. Baltzell K.A., Moghadassi M., Rice T., Sison J.D., and Wrensch M. Epithelial cells in nipple aspirate fluid and subsequent breast cancer risk: a historic prospective study. BMC Cancer 8 (2008) 75
30. Buehring G.C., Letscher A., McGirr K.M., Khandhar S., Che L.H., Nguyen C.T., et al. Presence of epithelial cells in nipple aspirate fluid is associated with subsequent breast cancer: a 25-year prospective study. Breast Cancer Res Treat 98 (2006) 63-70
31. Dooley W.C., Ljung B.M., Veronesi U., Cazzaniga M., Elledge R.M., O'Shaughnessy J.A., et al. Ductal lavage for detection of cellular atypia in women at high risk for breast cancer. J Natl Cancer Inst 93 (2001) 1624-1632
32. West K.E., Wojcik E.M., Dougherty T.A., Siziopikou K.P., Albain K.S., and Gabram S.G. Correlation of nipple aspiration and ductal lavage cytology with histopathologic findings for patients before scheduled breast biopsy examination. Am J Surg 191 (2006) 57-60
33. Zalles C.M., Kimler B.F., Simonsen M., Clark J.L., Metheny T., and Fabian C.J. Comparison of cytomorphology in specimens obtained by random periareolar fine needle aspiration and ductal lavage from women at high risk for development of breast cancer. Breast Cancer Res Treat 97 (2006) 191-197
34. Bhandare D., Nayar R., Bryk M., Hou N., Cohn R., Golewale N., et al. Endocrine biomarkers in ductal lavage samples from women at high risk for breast cancer. Cancer Epidemiol Biomarkers Prev 14 (2005) 2620-2627
35. Patil D.B., Lankes H.A., Nayar R., Masood S., Bryk M., Hou N., et al. Reproducibility of ductal lavage cytology and cellularity over a six month interval in high risk women. Breast Cancer Res Treat 112 (2008) 327-333
36. Mitchell G., Antill Y.C., Murray W., Kirk J., Salisbury E., Lindeman G.J., et al. Nipple aspiration and ductal lavage in women with a germline BRCA1 or BRCA2 mutation. Breast Cancer Res 7 (2005) R1122-R1131
37. Cazzaniga M., Severi G., Casadio C., Chiapparini L., Veronesi U., and Decensi A. Atypia and Ki-67 expression from ductal lavage in women at different risk for breast cancer. Cancer Epidemiol Biomarkers Prev 15 (2006) 1311-1315
38. Visvanathan K., Santor D., Ali S.Z., Hong I.S., Davidson N.E., and Helzlsouer K.J. The importance of cytologic intrarater and interrater reproducibility: the case of ductal lavage. Cancer Epidemiol Biomarkers Prev 15 (2006) 2553-2556
39. Seewaldt V.L., Goldenberg V., Jones L.W., Peace C., Broadwater G., Scott V., et al. Overweight and obese perimenopausal and postmenopausal women exhibit increased abnormal mammary epithelial cytology. Cancer Epidemiol Biomarkers Prev 16 (2007) 613-616
40. Ahn J., Schatzkin A., Lacey Jr. J.V., Albanes D., Ballard-Barbash R., Adams K.F., et al. Adiposity, adult weight change, and postmenopausal breast cancer risk. Arch Intern Med 167 (2007) 2091-2102
41. Carmichael A.R. Obesity as a risk factor for development and poor prognosis of breast cancer. BJOG 113 (2006) 1160-1166
42. Bushnaq Z.I., Ashfaq R., Leitch A.M., and Euhus D. Patient variables that predict atypical cytology by nipple duct lavage. Cancer 109 (2007) 1247-1254
43. Ferroni P., Basili S., Falco A., and Davi G. Inflammation, insulin resistance, and obesity. Curr Atheroscler Rep 6 (2004) 424-431
44. Lithgow D., Nyamathi A., Elashoff D., Martinez-Maza O., and Covington C. C-reactive protein in nipple aspirate fluid: relation to women's health factors. Nurs Res 55 (2006) 418-425
45. Lithgow D., Nyamathi A., Elashoff D., Martinez-Maza O., and Covington C. C-reactive protein in nipple aspirate fluid associated with Gail model factors. Biol Res Nurs 9 (2007) 108-116
46. Bacus J.W., Boone C.W., Bacus J.V., Follen M., Kelloff G.J., Kagan V., et al. Image morphometric nuclear grading of intraepithelial neoplastic lesions with applications to cancer chemoprevention trials. Cancer Epidemiol Biomarkers Prev 8 (1999) 1087-1094
47. Bartels P.H., Fabian C.J., Kimler B.F., Ranger-Moore J.R., Frank D.H., Yozwiak M.L., et al. Karyometry of breast epithelial cells acquired by random periareolar fine needle aspiration in women at high risk for breast cancer. Anal Quant Cytol Histol 29 (2007) 63-70
48. Cui Y., Page D.L., Chlebowski R.T., Beresford S.A., Hendrix S.L., Lane D.S., et al. Alcohol and folate consumption and risk of benign proliferative epithelial disorders of the breast. Int J Cancer 121 (2007) 1346-1351
49. Axelrod D.E., Miller N.A., Lickley H.L., Qian J., Christens-Barry W.A., Yuan Y., et al. Effect of quantitative nuclear image features on recurrence of ductal carcinoma in situ (DCIS) of the breast. Cancer Inf 6 (2008) 99-109
50. Marshall C.J., Schumann G.B., Ward J.H., Riding J.M., Cannon-Albright L., and Skolnick M. Cytologic identification of clinically occult proliferative breast disease in women with a family history of breast cancer. Anat Pathol 95 (1991) 157-165
51. King E.B., Chew K.L., Hom J.D., Duarte L.A., Mayall B., Miller T.R., et al. Characterization by image cytometry of duct epithelial proliferative disease of the breast. Mod Pathol 4 (1991) 291-296
52. Ljung B.M., Chew K.L., Moore II D.H., and King E.B. Cytology of ductal lavage fluid of the breast. Diagn Cytopathol 30 (2004) 143-150